Discovery of biphenyl-based VEGFR-2 inhibitors. Part 3: Design, synthesis and 3D-QSAR studies

Bioorganic & Medicinal Chemistry
2015.0

Abstract

VEGFR-2 plays an essential role in angiogenesis and is a central target for anticancer drug discovery. In order to develop novel VEGFR-2 inhibitors, we designed and synthesized 33 biphenyl amides based on our previously reported lead compound. The biological results indicated that four compounds (18b, 20e, 20h and 20j) are potent VEGFR-2 inhibitors which are comparable to positive control. Compound 18b displayed the most potent VEGFR-2 inhibition with IC50 value of 2.02nM. Moreover, it exhibited promising antiproliferative activity against MCF-7 and SMMC-7721 cells with IC50 values of 1.47μM and 5.98μM, respectively. Molecular docking and 3D-QSAR studies were also carried out. The results indicated that these biphenyl amides could serve as promising leads for further optimization as novel VEGFR-2 inhibitors.

DOI： 10.1016/j.bmc.2015.01.006

Knowledge Graph

Similar Paper

Discovery of biphenyl-based VEGFR-2 inhibitors. Part 3: Design, synthesis and 3D-QSAR studies
Bioorganic & Medicinal Chemistry 2015.0
Discovery of novel VEGFR-2 inhibitors embedding 6,7-dimethoxyquinazoline and diarylamide fragments
Bioorganic & Medicinal Chemistry Letters 2021.0
Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: Design, synthesis and biological evaluation
Bioorganic & Medicinal Chemistry 2014.0
Discovery of biphenyl-aryl ureas as novel VEGFR-2 inhibitors. Part 4: Exploration of diverse hinge-binding fragments
Bioorganic & Medicinal Chemistry 2015.0
Discovery of novel VEGFR-2 inhibitors. Part 5: Exploration of diverse hinge-binding fragments via core-refining approach
European Journal of Medicinal Chemistry 2015.0
Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors
European Journal of Medicinal Chemistry 2014.0
Design, synthesis and biological evaluation of biphenyl urea derivatives as novel VEGFR-2 inhibitors
MedChemComm 2013.0
Discovery of arylamide-5-anilinoquinazoline-8-nitro derivatives as VEGFR-2 kinase inhibitors: Synthesis, in vitro biological evaluation and molecular docking
Bioorganic & Medicinal Chemistry Letters 2019.0
Discovery of novel picolinamide-based derivatives as novel VEGFR-2 kinase inhibitors: synthesis,in vitrobiological evaluation and molecular docking
MedChemComm 2018.0
Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors
European Journal of Medicinal Chemistry 2017.0